As with any medicine, the MHRA will keep the safety of gepotidacin under close review
The ‘265 Patent is based on Enanta’s July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists
Marksans Pharma gets USFDA nod for acid reflux drug
7-OH is a concentrated byproduct of the kratom plant and has shown potential for abuse by binding to opioid receptors
The transaction aligns with Aurobindo’s strategic objective to expand its U.S. manufacturing footprint by enhancing its existing domestic capabilities
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
Phosphate-based excipients provide higher bulk densities and enable the reduction of the tablet sizes
Subscribe To Our Newsletter & Stay Updated